OA09123A - Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles. - Google Patents
Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles.Info
- Publication number
- OA09123A OA09123A OA59610A OA59610A OA09123A OA 09123 A OA09123 A OA 09123A OA 59610 A OA59610 A OA 59610A OA 59610 A OA59610 A OA 59610A OA 09123 A OA09123 A OA 09123A
- Authority
- OA
- OAPI
- Prior art keywords
- prevention
- pharmaceutical composition
- sexually transmitted
- transmitted diseases
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Absorbent Articles And Supports Therefor (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8809418 | 1988-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA09123A true OA09123A (fr) | 1991-10-31 |
Family
ID=9368330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA59610A OA09123A (fr) | 1988-07-11 | 1989-07-11 | Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles. |
Country Status (38)
Country | Link |
---|---|
US (1) | US5439685A (lv) |
EP (1) | EP0351301B1 (lv) |
JP (1) | JPH0774164B2 (lv) |
KR (1) | KR0143231B1 (lv) |
CN (1) | CN1035038C (lv) |
AP (1) | AP108A (lv) |
AR (1) | AR243381A1 (lv) |
AT (1) | ATE97570T1 (lv) |
BR (1) | BR8903523A (lv) |
CA (1) | CA1341304C (lv) |
CZ (1) | CZ280722B6 (lv) |
DD (1) | DD283932A5 (lv) |
DE (1) | DE68910892T2 (lv) |
DK (1) | DK173527B1 (lv) |
ES (1) | ES2062065T3 (lv) |
FI (1) | FI101595B (lv) |
HK (1) | HK131095A (lv) |
HU (1) | HU206634B (lv) |
IE (1) | IE63115B1 (lv) |
IL (1) | IL90910A (lv) |
LT (1) | LT3754B (lv) |
LV (1) | LV10573B (lv) |
MA (1) | MA22036A1 (lv) |
MD (1) | MD406C2 (lv) |
MX (1) | MX170801B (lv) |
MY (1) | MY106242A (lv) |
NO (1) | NO178843C (lv) |
NZ (1) | NZ229891A (lv) |
OA (1) | OA09123A (lv) |
PL (1) | PL161848B1 (lv) |
PT (1) | PT91108B (lv) |
RU (1) | RU2065742C1 (lv) |
SK (1) | SK423889A3 (lv) |
TN (1) | TNSN89074A1 (lv) |
TR (1) | TR28353A (lv) |
UA (1) | UA26124A (lv) |
YU (1) | YU47899B (lv) |
ZA (1) | ZA895263B (lv) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02258718A (ja) * | 1989-03-31 | 1990-10-19 | Nippon Kayaku Co Ltd | ペースト状基剤及び製剤 |
US5693769A (en) * | 1991-12-13 | 1997-12-02 | Transcell Technologies, Inc. | Glycosylated steroid derivatives for transport across biological membranes and process for making and using same |
US5795870A (en) * | 1991-12-13 | 1998-08-18 | Trustees Of Princeton University | Compositions and methods for cell transformation |
IT1255450B (it) * | 1992-06-30 | 1995-10-31 | Montefarmaco Spa | Uso di acidi biliari come agenti antivirali |
CA2167537A1 (en) * | 1993-07-19 | 1995-02-02 | Tsuneo Ozeki | Hepatitis c virus proliferation inhibitor |
DE4341139C1 (de) * | 1993-12-02 | 1995-04-13 | Upmeyer Hans Juergen | Dimeticon zur Behandlung von Aphthen |
US5667492A (en) * | 1994-10-07 | 1997-09-16 | Columbia Laboratories, Inc. | Use and composition of an anti-sexually transmitted diseases formulation |
US5700679A (en) * | 1996-06-07 | 1997-12-23 | Novavax, Inc. | Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity |
WO1998010744A1 (en) * | 1996-09-12 | 1998-03-19 | Simon Everard Barton | Composition comprising an antiviral or antibacterial agent for preventing transmission of diseases |
US6759434B2 (en) | 1999-09-22 | 2004-07-06 | B. Ron Johnson | Anti-infective compositions, methods and systems for treating disordered tissue |
US6211243B1 (en) | 1999-09-22 | 2001-04-03 | B. Ron Johnson | Methods for treating cold sores with anti-infective compositions |
US8173709B2 (en) * | 1999-09-22 | 2012-05-08 | Quadex Pharmaceuticals, Llc | Anti-infective methods for treating pathogen-induced disordered tissues |
US20050232868A1 (en) * | 1999-10-19 | 2005-10-20 | The Procter & Gamble Company | Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions |
RU2274442C2 (ru) * | 2000-03-07 | 2006-04-20 | Раш-Презбитериан-Ст. Лук'С Медикал Сентер | Композиции и способы улавливания и инактивации патогенных микроорганизмов и сперматозоидов |
GB2414394B (en) * | 2001-04-11 | 2006-01-11 | Playtex Products Inc | Use of a catamenial tampon which comprises a non-ionic surfactant for the treatment of vaginal malodour |
US8093446B2 (en) * | 2001-04-11 | 2012-01-10 | Playtex Products, Inc. | Fibrous absorbent articles having malodor counteractant |
GB2415626B (en) * | 2001-04-11 | 2006-03-08 | Playtex Products Inc | Use of a catamenial tampon which comprises a cationic surfactant for the treatment of vaginal malodor |
DK1506781T3 (da) * | 2003-11-03 | 2005-06-13 | Peter-Hansen Volkmann | Vaginalplejesammensætning |
CA2621066C (en) * | 2005-08-29 | 2011-11-29 | Sepsicure L.L.C. | Method for treatment or prevention of conditions caused by gram-positive bacteria |
DE102006020644A1 (de) * | 2006-04-28 | 2007-10-31 | Bayer Innovation Gmbh | Antiseptikahaltige Silikonelastomere |
US8409557B2 (en) | 2006-09-28 | 2013-04-02 | Clji Ip Company, Llc | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
US8062631B2 (en) | 2006-09-28 | 2011-11-22 | Clji I.P. Company, Llc | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
AU2012203566B1 (en) * | 2008-03-27 | 2013-09-12 | Clji I.P. Company, Llc | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
KR101130754B1 (ko) | 2010-06-25 | 2012-03-28 | 제일약품주식회사 | 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물 |
RU2591786C2 (ru) | 2010-11-12 | 2016-07-20 | Дзе Юниверсити Оф Юта Рисерч Фаундейшн | Интравагинальные устройства для контролируемой доставки лубрикантов |
US10426761B2 (en) | 2011-04-19 | 2019-10-01 | Arms Pharmaceutical, Llc | Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof |
CN103619341A (zh) | 2011-04-19 | 2014-03-05 | Arms制药有限公司 | 抑制有害微生物的方法及其阻隔形成组合物 |
CA2781379C (en) | 2012-03-26 | 2013-09-03 | Clji Ip Company, Llc | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
US9125911B2 (en) | 2013-03-14 | 2015-09-08 | Quadex Pharmaceuticals, Llc | Combined systemic and topical treatment of disordered tissues |
US9549930B2 (en) | 2013-03-14 | 2017-01-24 | Quadex Pharmaceuticals, Llc | Combined systemic and topical treatment of disordered and/or prodromal stage tissue |
US9463180B2 (en) | 2013-03-14 | 2016-10-11 | Quadex Pharmaceuticals, Llc | Treatment of molluscum contagiosum |
KR102399883B1 (ko) * | 2021-02-09 | 2022-05-20 | 재단법인대구경북과학기술원 | 압출용 복합고분자 펠릿 및 이의 제조방법 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1161484A (en) * | 1965-08-20 | 1969-08-13 | Mediline Ag | Toilet Preparation |
SE353658B (lv) * | 1967-06-13 | 1973-02-12 | Dow Corning | |
US3710795A (en) * | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
US3770648A (en) * | 1971-07-12 | 1973-11-06 | Bristol Myers Co | Anhydrous aerosol foam |
BE791632A (fr) * | 1971-11-20 | 1973-05-21 | Schering Ag | Supports a base de caoutchouc siliconique pour agents medicamenteux |
US4393871A (en) * | 1977-06-27 | 1983-07-19 | Vli Corporation | Vaginal device |
US4228797A (en) * | 1978-09-25 | 1980-10-21 | Dickey Richard P | Intravaginal contraception method |
ZA827582B (en) * | 1981-11-06 | 1983-08-31 | Ansell Inc | Spermicidal condom |
ZA828965B (en) * | 1981-12-07 | 1984-07-25 | Syntex Inc | Disposable intravaginal contraceptive devices releasing 1-substituted imidazoles |
DE3204124A1 (de) * | 1982-02-06 | 1983-08-18 | Bayer Ag, 5090 Leverkusen | Antimykotische tampons mit hoher wirkstoff-freisetzung |
AU2272883A (en) * | 1982-12-22 | 1984-06-28 | Herpes Pharmaceutical Inc. | Pharmaceutical compositions of steriods for treatment of herpes simplex infections |
DE3346641A1 (de) * | 1983-12-23 | 1985-07-04 | Dynamit Nobel Ag, 5210 Troisdorf | Silanmodifizierte estergemische |
GB8402748D0 (en) * | 1984-02-02 | 1984-03-07 | Dunlop Ltd | Intravaginal device |
NL8600929A (nl) * | 1986-04-11 | 1987-11-02 | Fundatech Sa | Werkwijze voor het vervaardigen van een gemedicateerd wegwerp-pessarium en gemedicateerd wegwerp-pessarium. |
IT1213323B (it) * | 1986-08-07 | 1989-12-20 | Crinos Industria Farmaco | Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida |
US4952411A (en) * | 1987-02-25 | 1990-08-28 | Trustees Of Columbia University In The City Of New York | Method of inhibiting the transmission of AIDS virus |
GB8706313D0 (en) * | 1987-03-17 | 1987-04-23 | Health Lab Service Board | Treatment & prevention of viral infections |
FR2614525B1 (fr) * | 1987-04-29 | 1995-11-10 | Jacques Augros | Tampon en eponge elastique, notamment tampon vaginal |
US4922928A (en) * | 1988-08-17 | 1990-05-08 | Michael Burnhill | Vaginal device |
-
1989
- 1989-07-07 NO NO892826A patent/NO178843C/no unknown
- 1989-07-10 PT PT91108A patent/PT91108B/pt not_active IP Right Cessation
- 1989-07-10 MA MA21844A patent/MA22036A1/fr unknown
- 1989-07-10 ES ES89401979T patent/ES2062065T3/es not_active Expired - Lifetime
- 1989-07-10 HU HU893459A patent/HU206634B/hu not_active IP Right Cessation
- 1989-07-10 MY MYPI89000940A patent/MY106242A/en unknown
- 1989-07-10 AT AT89401979T patent/ATE97570T1/de not_active IP Right Cessation
- 1989-07-10 FI FI893340A patent/FI101595B/fi not_active IP Right Cessation
- 1989-07-10 RU SU4614544/14A patent/RU2065742C1/ru not_active IP Right Cessation
- 1989-07-10 DK DK198903402A patent/DK173527B1/da not_active IP Right Cessation
- 1989-07-10 UA UA4614544A patent/UA26124A/uk unknown
- 1989-07-10 MX MX016734A patent/MX170801B/es unknown
- 1989-07-10 AR AR89314348A patent/AR243381A1/es active
- 1989-07-10 IL IL9091089A patent/IL90910A/en not_active IP Right Cessation
- 1989-07-10 EP EP89401979A patent/EP0351301B1/fr not_active Expired - Lifetime
- 1989-07-10 TN TNTNSN89074A patent/TNSN89074A1/fr unknown
- 1989-07-10 DE DE89401979T patent/DE68910892T2/de not_active Expired - Fee Related
- 1989-07-10 YU YU135789A patent/YU47899B/sh unknown
- 1989-07-10 IE IE221889A patent/IE63115B1/en not_active IP Right Cessation
- 1989-07-10 CA CA000605271A patent/CA1341304C/fr not_active Expired - Fee Related
- 1989-07-11 CZ CS894238A patent/CZ280722B6/cs not_active IP Right Cessation
- 1989-07-11 CN CN89104829A patent/CN1035038C/zh not_active Expired - Lifetime
- 1989-07-11 TR TR00603/89A patent/TR28353A/xx unknown
- 1989-07-11 NZ NZ229891A patent/NZ229891A/xx unknown
- 1989-07-11 BR BR898903523A patent/BR8903523A/pt not_active IP Right Cessation
- 1989-07-11 PL PL89280531A patent/PL161848B1/pl unknown
- 1989-07-11 KR KR1019890009850A patent/KR0143231B1/ko not_active IP Right Cessation
- 1989-07-11 SK SK4238-89A patent/SK423889A3/sk unknown
- 1989-07-11 OA OA59610A patent/OA09123A/xx unknown
- 1989-07-11 ZA ZA895263A patent/ZA895263B/xx unknown
- 1989-07-11 JP JP1177278A patent/JPH0774164B2/ja not_active Expired - Fee Related
- 1989-07-11 AP APAP/P/1989/000133A patent/AP108A/en active
- 1989-07-11 DD DD89330678A patent/DD283932A5/de not_active IP Right Cessation
-
1992
- 1992-12-22 US US07/995,522 patent/US5439685A/en not_active Expired - Lifetime
-
1993
- 1993-02-25 LV LVP-93-140A patent/LV10573B/en unknown
- 1993-12-22 LT LTIP1660A patent/LT3754B/lt not_active IP Right Cessation
-
1994
- 1994-12-30 MD MD95-0089A patent/MD406C2/ro unknown
-
1995
- 1995-08-17 HK HK131095A patent/HK131095A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA09123A (fr) | Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles. | |
HU895444D0 (en) | Process for the preparation of ophthalmic pharmaceutical composition | |
MC1915A1 (fr) | Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant | |
MA22443A1 (fr) | Procede de preparation d'une composition pharmaceutique . | |
IL76561A (en) | Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases | |
DE69114871D1 (de) | Homokinetisches Universalgelenk des Plungertyps. | |
BE891987A (fr) | Composition pharmaceutique pour le traitement des maladies de la cavite buccale | |
FR2558372B1 (fr) | Composition medicamenteuse pour le traitement de l'acne | |
NO905327L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karbamoylderivater. | |
FR2718024B1 (fr) | Médicament et composition pharmaceutique pour le traitement de l'inflammation. | |
DZ1351A1 (fr) | Composition pharmaceutique pour la prévention des maladies sexuellement transmissibles. | |
FR2647115B1 (fr) | Composition pharmaceutique de nedocromil sodique | |
NO891574D0 (no) | Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser. | |
IL96455A0 (en) | Pharmaceutical compositions for the treatment of hsv | |
OA08609A (fr) | Composition pharmaceutique pour le traitement des infections bactériennes. | |
FR2668707B1 (fr) | Procede de preparation d'une composition pharmaceutique. | |
FR2626961B3 (fr) | Coupelle pour bougies | |
AU625716C (en) | Pharmaceutical composition for the prevention of sexually transmitted diseases | |
FR2548055B1 (fr) | Dispositif pour l'elimination des comprimes casses, notamment pour l'industrie pharmaceutique | |
MA26546A1 (fr) | Composition pharmaceutique pour le traitement de la dysmenorrhee et les accouchements prematures. | |
AP9000180A0 (en) | Pharmaceutical composition for the treatment of protozoal diseases | |
FR2770132B1 (fr) | Composition pharmaceutique pour le traitement de l'arteriopathie des membres inferieurs | |
FR2636239B1 (fr) | Composition desinfectante pour la prevention de la mammite subclinique chez les ruminants | |
FR2652747B1 (fr) | Application d'agents actifs pour la preparation d'un medicament destine au traitement de maladies auto-immunes. | |
MA21630A1 (fr) | Compositions pour le traitement de leishmanioses . |